Clinical Trial: National Liver Cancer Biomarker Screening Trial
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Carcinoma, Hepatocellular
Study Type: INTERVENTIONAL
Official Title: National Liver Cancer Biomarker Screening Trial
Brief Summary:
The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or patients with chronic hepatitis B infection.Eligible patients will be randomized in a 1:1 fashion to Arm A using semi-annual ultrasound and AFP-based screening or Arm B using semi-annual screening using GALAD alone.Randomization will be stratified by sex, enrolling site, Child Pugh class (A vs. B), and HCC etiology (viral…
Read more